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Background
• Heterogeneity of treatment effect (HTE), the phenomenon of individual variation in response to treatment has been well-established. Some individuals might respond well to a specific treatment, while others experience little to no benefit, or still others might experience harm as a result of the treatment. Because clinical trials often estimate only the average treatment effects, patient-level information about the benefits and risks of a treatment evidence is limited.
• Existing approaches to assessing HTE, whether in a randomized controlled trial (RCT) or observational study, vary in terms of methodological sophistication as well as the extent to which they can support valid causal inferences and inform clinical decision making.
• A recently conducted literature review on the topic found that most guidance documents related to HTE were focused on placebo-controlled studies, and that very little of this guidance was grounded in a PCOR/ CER perspective to research [6] . 
PCORI's work in this area
Literature Review Objectives
• Build on previous literature reviews examining the use of HTE methods in the analysis of clinical trials.
• Describe the use of HTE analysis, using a subset of clinical trials published in 2014.
• Assess consistency of conduct and reporting of HTE analyses with PCORI's Methodology Standards.
Methods
• Modify a previous literature review protocol to characterize the reports of HTE analyses (including subgroup analysis) in RCTs.
• Use the modified protocol to conduct a purposive literature review of RCTs to examine the use and reporting of methods for HTE analyses.
Eligibility Criteria
Inclusion criteria 1. The study is an RCT; 2. The participants are human; 3. The study is published in 2014 in a core clinical journal (as defined by the National Library of Medicine) and full free text is available (for PCORI staff). Exclusion criteria 1. The study is reported as a Research/comment Letter, Meta-Analysis, Review, News, or a Case Report (121 studies excluded based on Ovid assessment of article type); 2. The report does not include the entire population enrolled in the original study (i.e. the report focuses on a subset of the original study population); 3. The study is explicitly labelled as a phase I trial.
Data Extraction and Measures
• A standard electronic form and database were used to collect key information about studies selected for analysis, including the clinical condition under study, country of the first author's institution, the total number of participants randomized, the number of treatment arms, the unit of randomization, and study funding sources.
• Studies were then examined to determine if they included HTE analysis, subgroup analysis only, or neither. • PCORI's Methodology Standards for HTE were used to assess the studies. For each of the three standards, reviewers were asked to assess whether, based on the information included in the published article, (1) the study met particular key elements of the standard, and (2) in the overall judgment of the reviewer, the study met the standard.
Results
• Out of the 100 randomly selected articles included in our review, 64 met our inclusion criteria and 37 did not.
• The most common reason for exclusion was a trial design other than RCT (e.g., systematic reviews, memos, and research letters).
• Of the 64 included studies, 48% (n=31) were published in the Journal of the American Medical Association (JAMA), 22% (n=14) from the New England Journal of Medicine, and 30% (n=19) from other journals.
• A significant portion (42%) of studies reviewed reported HTE analyses that employed a formal test for heterogeneity or treatment by covariate interaction, including interaction tests, differences in treatment effect estimates with standard errors, or other methods to account for multiple comparisons (n=27).
• A further 20% (n=13) of studies reported the use of subgroup an analyses without use of a formal test for heterogeneity or interaction.
• The remaining 39% of the RCTs examined did not report that use of any HTE or subgroup analysis (n=24). 
